[en] Here, we present a series of illustrated capsules from the State of the Art (SOA) speakers at the 2024 International Society on Thrombosis and Haemostasis Congress in Bangkok, Thailand. This year's Congress marks the first time that the International Society on Thrombosis and Haemostasis has held its flagship scientific meeting in Southeast Asia and is the first to be organized by an international Planning Committee. The Bangkok program will feature innovative science and clinical updates from around the world, reflecting the diversity and multidisciplinary growth of our field. In these illustrated SOA capsules, you will find an exploration of novel models of thrombosis and bleeding and biomaterial discoveries that can trigger or block coagulation. Thromboinflammation is now understood to drive many disease states, and the SOA speakers cover cellular and coagulation responses to COVID-19 and other infections. The theme of crosstalk between coagulation and inflammation expands with capsules on protein S signaling, complement, and fibrinolytic inhibitors. Novel agents for hemophilia and thrombosis prevention are introduced. Challenging clinical conditions are also covered, such as inherited platelet disorders and antiphospholipid antibody syndrome. The scientific program in Bangkok will also showcase the work of clinicians and scientists from all parts of the world and chronicle real-world challenges. For example, 2 SOA capsules address the diagnosis and management of von Willebrand disease in low-income settings. Take some time to browse through these short illustrated reviews; we're sure that you'll be entertained, educated, and inspired to further explore the world of thrombosis and hemostasis.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Ward, Chris; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
Curry, Nicola; Oxford University and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
El-Ekiaby, Magdy; Shabrawishi Hospital Hematology Unit, Cairo, Egypt
Jurk, Kerstin; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
Versteeg, Henri H; Leiden University Medical Center, Leiden, the Netherlands
Keragala, Charithani; Australian Centre for Blood Diseases, the Central Clinical School, Monash University, Melbourne, Victoria, Australia ; Department of Haematology, Monash Health, Clayton, Victoria, Australia
Burstyn-Cohen, Tal; Institute for Biomedical and Oral Research (IBoR), The Hebrew University of Jerusalem, Jerusalem, Israel
Antoniak, Silvio; UNC Blood Research Center, Department of Pathology and Laboratory Medicine, UNC Lineberger Comprehensive Cancer Center, UNC McAllister Heart Institute, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Suzuki, Yuko; Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan
Baker, Ross I; Perth Blood Institute, Murdoch University, Perth, Western Australia, Australia
Christophe, Olivier; Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose (HITh U1176), Le Kremlin-Bicêtre, France
Revel-Vilk, Shoshana; Pediatric Hematology/Oncology, Shaare Zedek Medical Center, Jerusalem, Israel ; School of Medicine, Hebrew University, Jerusalem, Israel
Hart, Alice; Imperial College London, Imperial College Healthcare NHS Trust, London, United Kingdom
Deppermann, Carsten; Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany
Tran, Huyen; The Alfred Hospital, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
Pozzi, Nicola; Saint Louis University, St. Louis, Missouri, USA
Kahr, Walter H A; Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Grover, Steven P; UNC Blood Research Center, Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Wenzel, Philip; University Medical Center Mainz, Mainz, Germany
Brown, Ashley C; Joint Department of Biomedical Engineering at North Carolina State University and the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Oury, Cécile ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Shea, Susan M; Trauma and Transfusion Medicine Research Center, Department of Surgery and Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Passam, Freda H; University of Sydney, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Winearls, James; Gold Coast University Hospital, St Andrews War Memorial Hospital, Monash University, University of Queensland, Brisbane, Queensland, Australia
Moore, Hunter B; AdventHealth Transplant Institution at Porter, Denver, Colorado, USA
Tole, Soumitra; Children's Hospital, London Health Sciences Center, Western University, London, United Kingdom
Merriman, Eileen; North Shore Hospital, Auckland, New Zealand
Barnes, Geoffrey D; Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, USA
Liu, Z Leonardo; Florida State University, Tallahassee, Florida, USA
Sholzberg, Michelle; St Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada
World Health Organisation. Global Health Estimates 2016: Death by Cause, Age, Sex, by Country and by Region, 2000-2016, 2018 https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death. (Accessed 29 March 2024)
Walsh, M., Moore, E.E., Moore, H.B., Thomas, S., Kwaan, H.C., Speybroeck, J., et al. Whole blood, fixed ratio, or goal-directed blood component therapy for the initial resuscitation of severely hemorrhaging trauma patients: a narrative review. J Clin Med, 10, 2021, 320, 10.3390/jcm10020320.
Burstyn-Cohen, T., Fresia, R., TAM receptors in phagocytosis: beyond the mere internalization of particles. Immunol Rev 319 (2023), 7–26.
Soucie, J.M., Miller, C.H., Byams, V.R., Payne, A.B., Abe, K., Sidonio, R.F., et al. Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States. Haemophilia 27 (2021), 445–453.
Atiq, F., Blok, R., van Kwawegen, C.B., Doherty, D., Lavin, M., van der Bom, J.G., et al. Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies. Blood 143 (2024), 1414–1424.
Cooper, N., Kruse, A., Kruse, C., Watson, S., Morgan, M., Provan, D., et al. Immune thrombocytopenia (ITP) World Impact Survey (IWISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatment. Am J Hematol 96 (2021), 188–198.
Cooper, N., Morrison, M.A., Vladescu, C., Hart, A.C., Paul, D., Malik, A., et al. Identification of occult cerebral microbleeds in adults with immune thrombocytopenia. Blood 136 (2020), 2875–2880.
Vladescu, C., Hart, A.C., Paul, D., Ademokun, C., Teklemichael, A., Chivers, B., et al. Cognitive impairment in patients with immune thrombocytopenia. Blood 140:Suppl 1 (2022), 5553–5554.
Kumar, S., Wulf, J. 2nd, Basore, K., Pozzi, N., Structural analyses of β2-glycoprotein I: is there a circular conformation?. J Thromb Haemost 21 (2023), 3511–3521.
Kumar, S., Summers, B., Basore, K., Pengo, V., Flaumenhaft, R., Pozzi, N., Cryo-EM structure and functional basis of prothrombin recognition by a type-I anti-prothrombin antiphospholipid antibody. Blood, Published online February 18, 2024, 10.1182/blood.2023022942.
Liu, R.J., Al-Molieh, Y., Chen, S.Z., Drobac, M., Urban, D., Chen, C.H., et al. The Sec1-Munc18 protein VPS33B forms a uniquely bidirectional complex with VPS16B. J Biol Chem, 299, 2023, 104718, 10.1016/j.jbc.2023.104718.
Lo, R.W., Li, L., Leung, R., Pluthero, F.G., Kahr, W.H., NBEAL2 (neurobeachin-like 2) is required for retention of cargo proteins by alpha-granules during their production by megakaryocytes. Arterioscler Thromb Vasc Biol 38 (2018), 2435–2447.
Bowman, S.L., Bi-Karchin, J., Le, L., Marks, M.S., The road to lysosome-related organelles: insights from Hermansky-Pudlak syndrome and other rare diseases. Traffic 20 (2019), 404–435.
Grover, S.P., Sundler Björkman, L., Egesten, A., Moll, S., Mackman, N., Hereditary angioedema is associated with an increased risk of venous thromboembolism. J Thromb Haemost 20 (2022), 2703–2706.
Grover, S.P., Kawano, T., Wan, J., Tanratana, P., Polai, Z., Shim, Y.J., et al. C1 inhibitor deficiency enhances contact pathway-mediated activation of coagulation and venous thrombosis. Blood 141 (2023), 2390–2401.
Grover, S.P., Snir, O., Hindberg, K., Englebert, T.M., Braekkan, S.K., Morelli, V.M., et al. High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism. J Thromb Haemost 21 (2023), 1849–1860.
Kossmann, S., Lagrange, J., Jäckel, S., Jurk, K., Ehlken, M., Schönfelder, T., et al. Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension. Sci Transl Med, 9, 2017, eaah4923, 10.1126/scitranslmed.aah4923.
Garlapati, V., Molitor, M., Michna, T., Harms, G.S., Finger, S., Jung, R., et al. Targeting myeloid cell coagulation signaling blocks MAP kinase/TGF-β1-driven fibrotic remodeling in ischemic heart failure. J Clin Invest, 133, 2023, e156436, 10.1172/JCI156436.
Sekhon, U.D., Swingle, K., Girish, A., Luc, N., de la Fuente, M., Alvikas, J., et al. Platelet-mimicking procoagulant nanoparticles augment hemostasis in animal models of bleeding. Sci Transl Med, 14, 2022, eabb8975, 10.1126/scitranslmed.abb8975.
Chee, E., Mihalko, E., Nellenbach, K., Sollinger, J., Huang, K., Hon, M., et al. Wound-triggered shape change microgels for the development of enhanced biomimetic function platelet-like particles. J Biomed Mater Res A 112 (2024), 613–624.
Higashikuni, Y., Liu, W., Obana, T., Sata, M., Pathogenic basis of thromboinflammation and endothelial injury in COVID-19: current findings and therapeutic implications. Int J Mol Sci, 22, 2021, 120812, 10.3390/ijms222112081.
Dupuy, A., Liu, X., Tieng, J., Johnston, B., Nasser, A., Coleman, P., et al. Endothelial cell activation enhances thromboinflammation in VITT. Blood 140 (2022), 1656–1657.
Warkentin, T.E., Baskin-Miller, J., Raybould, A.L., Sheppard, J.I., Daka, M., Nazy, I., et al. Adenovirus-associated thrombocytopenia, thrombosis, and VITT-like antibodies. N Engl J Med 389 (2023), 574–577.
Fabes, J., Brunskill, S.J., Curry, N., Doree, C., Stanworth, S.J., Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia. Cochrane Database Syst Rev, 12, 2018, CD010649, 10.1002/14651858.CD010649.pub2.
Godier, A., Greinacher, A., Faraoni, D., Levy, J.H., Samama, C.M., Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH. J Thromb Haemost 16 (2018), 170–174.
Mitra, B., Jorgensen, M., Reade, M.C., Keegan, A., Holley, A., Farmer, S., et al. Patient blood management guideline for adults with critical bleeding. Med J Aust 220 (2024), 211–216.
Kuenzig, M.E., Bitton, A., Carroll, M.W., Kaplan, G.G., Otley, A.R., Singh, H., et al. Inflammatory bowel disease increases the risk of venous thromboembolism in children: a population-based matched cohort study. J Crohns Colitis 15 (2021), 2031–2040.
Aardoom, M.A., Klomberg, R.C.W., Kemos, P., Ruemmele, F.M., PIBD-VTE Group. van Ommen, C.H.H., et al. The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease: a prospective international cohort study based on the PIBD-SETQuality Safety Registry. J Crohns Colitis 16 (2022), 695–707.
De Laffolie, J., Ballauff, A., Wirth, S., Blueml, C., Rommel, F.R., Claßen, M., et al. Occurrence of thromboembolism in paediatric patients with inflammatory bowel disease: data from the CEDATA-GPGE Registry. Front Pediatr, 10, 2022, 883183, 10.3389/fped.2022.883183.
Liu, Z.L., Ku, D.N., Aidun, C.K., Mechanobiology of shear-induced platelet aggregation leading to occlusive arterial thrombosis: A multiscale in silico analysis. J Biomechanics, 120, 2021, 110349.
Liu, Z.L., Bresette, C., Aidun, C.K., Ku, D.N., SIPA in 10 milliseconds: VWF tentacles agglomerate and capture platelets under high shear. Blood Adv 6 (2022), 2453–2465.
Liu, Z.L., Ku, D.N., Aidun, C.K., Mechanobiology of shear-induced platelet aggregation leading to occlusive arterial thrombosis: a multiscale in silico analysis. J Biomech, 120, 2021, 110349, 10.1016/j.jbiomech.2021.110349.
Liu, Z., Zhu, Y., Clausen, J.R., Lechman, J.B., Rao, R.R., Aidun, C.K., Multiscale method based on coupled lattice-Boltzmann and Langevin-dynamics for direct simulation of nanoscale particle/polymer suspensions in complex flows. Int J Numer Methods Fluids 91 (2019), 228–246.
